Search research articles
Contact Us
Filters
Showing results (61-70 of 117) with videos related to
Page
of 12
Sort By:
Systematic Reviews
|
November 4, 2022
Generating evidence for diagnosis and therapy of RarE LIVEr disease: the RELIVE Initiative for systematic reviews and meta-analyses
Juri Fuchs, Anastasia Murtha-Lemekhova, Jan Pfeiffenberger, et al.
International Journal of Cancer
|
April 23, 2020
Blood markers of oxidative stress are strongly associated with poorer prognosis in colorectal cancer patients
Daniel Boakye, Lina Jansen, Ben Schöttker, et al.
The American Journal of Clinical Nutrition
|
March 19, 2021
The association of vitamin D with survival in colorectal cancer patients depends on antioxidant capacity
Daniel Boakye, Lina Jansen, Ben Schöttker, et al.
Oncoimmunology
|
June 15, 2018
Large-scale database mining reveals hidden trends and future directions for cancer immunotherapy
Jakob Nikolas Kather, Anna Sophie Berghoff, Dyke Ferber, et al.
Cancer Research
|
July 4, 2018
High-Throughput Screening of Combinatorial Immunotherapies with Patient-Specific <i>In Silico</i> Models of Metastatic Colorectal Cancer
Jakob Nikolas Kather, Pornpimol Charoentong, Meggy Suarez-Carmona, et al.
Annals of Surgical Oncology
|
March 17, 2015
Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma
Fee Klupp, Johannes Diers, Christoph Kahlert, et al.
Oncoimmunology
|
June 5, 2013
Hepatic metastases of colorectal cancer are rather homogeneous but differ from primary lesions in terms of immune cell infiltration
Niels Halama, Anna Spille, Tina Lerchl, et al.
Cancer Immunology, Immunotherapy : CII
|
August 22, 2018
IL-10 inducible CD8<sup>+</sup> regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells
Julian Plaumann, Melanie Engelhardt, Mohamed H S Awwad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2011
Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines
Niels Halama, Monika Braun, Christoph Kahlert, et al.
British Journal of Clinical Pharmacology
|
March 25, 2020
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours
Devalingam Mahalingam, Manish R Patel, Jasgit C Sachdev, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 117) with videos related to
Sort By:
Page
of 12
Systematic Reviews
|
November 4, 2022
Generating evidence for diagnosis and therapy of RarE LIVEr disease: the RELIVE Initiative for systematic reviews and meta-analyses
Juri Fuchs, Anastasia Murtha-Lemekhova, Jan Pfeiffenberger, et al.
International Journal of Cancer
|
April 23, 2020
Blood markers of oxidative stress are strongly associated with poorer prognosis in colorectal cancer patients
Daniel Boakye, Lina Jansen, Ben Schöttker, et al.
The American Journal of Clinical Nutrition
|
March 19, 2021
The association of vitamin D with survival in colorectal cancer patients depends on antioxidant capacity
Daniel Boakye, Lina Jansen, Ben Schöttker, et al.
Oncoimmunology
|
June 15, 2018
Large-scale database mining reveals hidden trends and future directions for cancer immunotherapy
Jakob Nikolas Kather, Anna Sophie Berghoff, Dyke Ferber, et al.
Cancer Research
|
July 4, 2018
High-Throughput Screening of Combinatorial Immunotherapies with Patient-Specific <i>In Silico</i> Models of Metastatic Colorectal Cancer
Jakob Nikolas Kather, Pornpimol Charoentong, Meggy Suarez-Carmona, et al.
Annals of Surgical Oncology
|
March 17, 2015
Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma
Fee Klupp, Johannes Diers, Christoph Kahlert, et al.
Oncoimmunology
|
June 5, 2013
Hepatic metastases of colorectal cancer are rather homogeneous but differ from primary lesions in terms of immune cell infiltration
Niels Halama, Anna Spille, Tina Lerchl, et al.
Cancer Immunology, Immunotherapy : CII
|
August 22, 2018
IL-10 inducible CD8<sup>+</sup> regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells
Julian Plaumann, Melanie Engelhardt, Mohamed H S Awwad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2011
Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines
Niels Halama, Monika Braun, Christoph Kahlert, et al.
British Journal of Clinical Pharmacology
|
March 25, 2020
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours
Devalingam Mahalingam, Manish R Patel, Jasgit C Sachdev, et al.
Page
of 12